PF-Atlas › Clinical Trials › NCT00455767

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome Patients

EPI-hNE4 · Phase 2

Registry ID

NCT00455767

Phase

Phase 2

Status

Completed

Drug / intervention

EPI-hNE4

Sponsor

Debiopharm International SA

Start

2006-07

Enrollment

Locations

About this trial

The study is aimed to assess safety of Depelestat treatment, as well as efficacy on prevention and treatment of alveolar inflammation in early pulmonary fibrosis in patients suffering from persistent Acute Respiratory Distress Syndrome.

View NCT00455767 on ClinicalTrials.gov →

Explore related

All EPI-hNE4 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00455767 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.